Suppr超能文献

微小RNA-106b作为一种新兴的癌症治疗靶点。

miR-106b as an emerging therapeutic target in cancer.

作者信息

Sagar Surendra Kumar

机构信息

Department of Zoology, Swami Shraddhanand College, University of Delhi, Delhi 110036, India.

出版信息

Genes Dis. 2021 Feb 12;9(4):889-899. doi: 10.1016/j.gendis.2021.02.002. eCollection 2022 Jul.

Abstract

MicroRNAs (miRNAs) comprise short non-coding RNAs that function in regulating the expression of tumor suppressors or oncogenes and modulate oncogenic signaling pathways in cancer. miRNAs expression alters significantly in several tumor tissues and cancer cell lines. For example, miR-106b functions as an oncogene and increases in multiple cancers. The miR-106b directly targets genes involved in tumorigenesis, proliferation, invasion, migration, and metastases. This review has focused on the miR-106b function and its downstream target in different cancers and provide perspective into how miR-106 regulates cancer cell proliferation, migration, invasion, and metastases by regulating the tumor suppressor genes. Since miRNAs-based therapies are currently being developed to enhance cancer therapy outcomes, miR-106b could be an attractive and prospective candidate in different cancer types for detection, diagnosis, and prognosis assessment in the tumor.

摘要

微小RNA(miRNA)是一类短链非编码RNA,其功能是调节肿瘤抑制因子或癌基因的表达,并在癌症中调控致癌信号通路。miRNA的表达在多种肿瘤组织和癌细胞系中发生显著改变。例如,miR-106b作为一种癌基因,在多种癌症中表达上调。miR-106b直接靶向参与肿瘤发生、增殖、侵袭、迁移和转移的基因。本综述聚焦于miR-106b在不同癌症中的功能及其下游靶点,并探讨miR-106如何通过调节肿瘤抑制基因来调控癌细胞的增殖、迁移、侵袭和转移。由于目前正在开发基于miRNA的疗法以提高癌症治疗效果,miR-106b可能是不同癌症类型中用于肿瘤检测、诊断和预后评估的一个有吸引力的潜在候选分子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0d5/9170583/7d006e5f8c99/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验